Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2018 Filed May 2, 2018 19:01 UTC |
Powell Kendall JDirector
|
Tax withholdingOrdinary Shares | 616 | $81.01 | $49,902.16 |
DisclosureSEC source: 0001127602-18-015918 · form4.xml · nonDerivative · entry 2 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,258 Read SEC document |
| May 01, 2018 Filed May 2, 2018 18:55 UTC |
DONNELLY SCOTT CDirector
|
Tax withholdingOrdinary Shares | 616 | $81.01 | $49,902.16 |
DisclosureSEC source: 0001127602-18-015913 · form4.xml · nonDerivative · entry 2 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,259 Read SEC document |
| May 01, 2018 Filed May 2, 2018 18:54 UTC |
ARNOLD CRAIGDirector
|
Tax withholdingOrdinary Shares | 616 | $81.01 | $49,902.16 |
DisclosureSEC source: 0001127602-18-015912 · form4.xml · nonDerivative · entry 2 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,001 Read SEC document |
| May 01, 2018 Filed May 2, 2018 15:07 UTC |
Lenehan James TDirector
|
Tax withholdingOrdinary Shares | 616 | $81.01 | $49,902.16 |
DisclosureSEC source: 0001127602-18-015926 · form4.xml · nonDerivative · entry 2 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,734 Read SEC document |
| May 01, 2018 Filed May 2, 2018 18:57 UTC |
HOGAN RANDALL JDirector
|
Tax withholdingOrdinary Shares | 616 | $81.01 | $49,902.16 |
DisclosureSEC source: 0001127602-18-015914 · form4.xml · nonDerivative · entry 2 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,527 Read SEC document |
| May 01, 2018 Filed May 2, 2018 18:52 UTC |
ANDERSON RICHARD HDirector
|
Tax withholdingOrdinary Shares | 616 | $81.01 | $49,902.16 |
DisclosureSEC source: 0001127602-18-015911 · form4.xml · nonDerivative · entry 2 ANDERSON RICHARD H · CIK 0001200334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,149 Read SEC document |
| May 01, 2018 Filed May 2, 2018 14:59 UTC |
POZEN ROBERT CDirector
|
Tax withholdingOrdinary Shares | 616 | $81.01 | $49,902.16 |
DisclosureSEC source: 0001127602-18-015916 · form4.xml · nonDerivative · entry 2 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,167 Read SEC document |
| May 01, 2018 Filed May 2, 2018 19:05 UTC |
NABEL ELIZABETH GDirector
|
Tax withholdingOrdinary Shares | 616 | $81.01 | $49,902.16 |
DisclosureSEC source: 0001127602-18-015924 · form4.xml · nonDerivative · entry 2 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,400 Read SEC document |
| April 30, 2018 Filed May 2, 2018 15:04 UTC |
OLEARY DENISE MDirector
|
GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015922 · form4.xml · nonDerivative · entry 1 OLEARY DENISE M · CIK 0001145159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,882 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. Read SEC document |
| April 30, 2018 Filed May 2, 2018 18:59 UTC |
JACKSON SHIRLEY ADirector
|
GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015915 · form4.xml · nonDerivative · entry 1 JACKSON SHIRLEY A · CIK 0001168019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,141 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 810 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 30, 2018 Filed May 2, 2018 19:01 UTC |
Powell Kendall JDirector
|
GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015918 · form4.xml · nonDerivative · entry 1 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,874 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 509 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 30, 2018 Filed May 2, 2018 18:55 UTC |
DONNELLY SCOTT CDirector
|
GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015913 · form4.xml · nonDerivative · entry 1 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,875 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 95 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 30, 2018 Filed May 2, 2018 18:54 UTC |
ARNOLD CRAIGDirector
|
GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015912 · form4.xml · nonDerivative · entry 1 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,617 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 48 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 30, 2018 Filed May 2, 2018 15:07 UTC |
Lenehan James TDirector
|
GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015926 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,350 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased 139 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 30, 2018 Filed May 2, 2018 18:57 UTC |
HOGAN RANDALL JDirector
|
GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015914 · form4.xml · nonDerivative · entry 1 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,143 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 48 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 30, 2018 Filed May 2, 2018 18:52 UTC |
ANDERSON RICHARD HDirector
|
GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015911 · form4.xml · nonDerivative · entry 1 ANDERSON RICHARD H · CIK 0001200334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,765 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 672 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 30, 2018 Filed May 2, 2018 14:59 UTC |
POZEN ROBERT CDirector
|
GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015916 · form4.xml · nonDerivative · entry 1 POZEN ROBERT C · CIK 0001278408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,783 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased 613 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 30, 2018 Filed May 2, 2018 19:00 UTC |
LEAVITT MICHAEL ODirector
|
GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015917 · form4.xml · nonDerivative · entry 1 LEAVITT MICHAEL O · CIK 0001536118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,089 F1 · kind: This restricted stock unit award will vest on the one-year anniversary of the grant date. F2 · balance_after: This balance increased by 214 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 30, 2018 Filed May 2, 2018 19:05 UTC |
NABEL ELIZABETH GDirector
|
GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015924 · form4.xml · nonDerivative · entry 1 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,016 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 48 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 18:49 UTC |
OLEARY DENISE MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,590 | $0.00 Strike: $50.34 | $0.00 |
DisclosureSEC source: 0001127602-18-014898 · form4.xml · derivative · entry 2 OLEARY DENISE M · CIK 0001145159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,590 shares Expires 2018-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 1,590 New Medtronic ordinary shares for $50.34 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,590 Medtronic common stock shares for $50.34 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 18:49 UTC |
OLEARY DENISE MDirector
|
Exercise / conversionOrdinary Shares | 1,590 | $50.34 | $80,040.60 |
DisclosureSEC source: 0001127602-18-014898 · form4.xml · nonDerivative · entry 1 OLEARY DENISE M · CIK 0001145159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This balance increased by 548 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 17:27 UTC |
Lenehan James TDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,590 | $0.00 Strike: $50.34 | $0.00 |
DisclosureSEC source: 0001127602-18-011591 · form4.xml · derivative · entry 3 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,590 shares Expires 2018-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 1,590 New Medtronic ordinary shares for $50.34 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,590 Medtronic common stock shares for $50.34 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 17:27 UTC |
Lenehan James TDirector
|
SaleOrdinary Shares | 1,306 | $83.56 | $109,122.83 |
DisclosureSEC source: 0001127602-18-011591 · form4.xml · nonDerivative · entry 2 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,028 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 17:27 UTC |
Lenehan James TDirector
|
Exercise / conversionOrdinary Shares | 1,590 | $50.34 | $80,040.60 |
DisclosureSEC source: 0001127602-18-011591 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This balance increased 391 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC |
Surface Carol ASVP, Chief HR Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,195 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · derivative · entry 10 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,374 Underlying: Ordinary Shares · 1,195 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. F5 · derivative.exercise_date: This option to purchase 30,275 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,275 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC |
Surface Carol ASVP, Chief HR Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,706 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · derivative · entry 9 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,569 Underlying: Ordinary Shares · 22,706 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. F5 · derivative.exercise_date: This option to purchase 30,275 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,275 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC |
Surface Carol ASVP, Chief HR Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 24,719 | $0.00 Strike: $57.65 | $0.00 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · derivative · entry 8 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,239 Underlying: Ordinary Shares · 24,719 shares Expires 2023-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 32,958 New Medtronic ordinary shares for $57.65 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 32,958 Medtronic common stock shares for $57.65 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC |
Surface Carol ASVP, Chief HR Officer
|
Tax withholdingOrdinary Shares | 40,338 | $79.74 | $3,216,552.12 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 6 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,813 Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC |
Surface Carol ASVP, Chief HR Officer
|
Exercise / conversionOrdinary Shares | 1,195 | $62.76 | $74,998.20 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 5 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC |
Surface Carol ASVP, Chief HR Officer
|
Exercise / conversionOrdinary Shares | 22,706 | $62.76 | $1,425,028.56 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 4 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC |
Surface Carol ASVP, Chief HR Officer
|
Exercise / conversionOrdinary Shares | 24,719 | $57.65 | $1,425,050.35 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 3 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC |
Surface Carol ASVP, Chief HR Officer
|
SaleOrdinary Shares | 12,479 | $78.36 | $977,854.44 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 2 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,531 F2 · price: The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.340 to $78.440, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:09 UTC |
Surface Carol ASVP, Chief HR Officer
|
SaleOrdinary Shares | 12,000 | $78.00 | $936,000.00 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,010 F1 · balance_after: This balance increased by 140 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| February 18, 2018 Filed Feb 20, 2018 14:56 UTC |
WHITE ROBERT JOHNEVP & President MITG
|
Tax withholdingOrdinary Shares | 1,472 | $83.31 | $122,632.32 |
DisclosureSEC source: 0001127602-18-007076 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,890 F1 · balance_after: This balance increased by 218 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| January 09, 2018 Filed Jan 10, 2018 22:40 UTC |
Kuntz RichardSrVP & Chief Scien, Clin, Reg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 45,872 | $0.00 Strike: $34.88 | $0.00 |
DisclosureSEC source: 0001127602-18-001566 · form4.xml · derivative · entry 5 Kuntz Richard · CIK 0001341125 · SrVP & Chief Scien, Clin, Reg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 45,872 shares Expires 2021-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 45,872 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 45,872 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| January 09, 2018 Filed Jan 10, 2018 22:40 UTC |
Kuntz RichardSrVP & Chief Scien, Clin, Reg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,492 | $0.00 Strike: $37.53 | $0.00 |
DisclosureSEC source: 0001127602-18-001566 · form4.xml · derivative · entry 4 Kuntz Richard · CIK 0001341125 · SrVP & Chief Scien, Clin, Reg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 35,492 shares Expires 2020-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 35,492 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 35,492 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| January 09, 2018 Filed Jan 10, 2018 22:40 UTC |
Kuntz RichardSrVP & Chief Scien, Clin, Reg
|
SaleOrdinary Shares | 78,526 | $86.21 | $6,769,726.46 |
DisclosureSEC source: 0001127602-18-001566 · form4.xml · nonDerivative · entry 3 Kuntz Richard · CIK 0001341125 · SrVP & Chief Scien, Clin, Reg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,107 F1 · security: This balance increased by 324 shares due to exempt transactions such as dividend reinvestment. F2 · price: The price reported in Column 4 is a weighted Average price. The shares were sold in multiple transactions at prices ranging from $86.12 to $86.26, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4. Read SEC document |
| January 09, 2018 Filed Jan 10, 2018 22:40 UTC |
Kuntz RichardSrVP & Chief Scien, Clin, Reg
|
Exercise / conversionOrdinary Shares | 45,872 | $34.88 | $1,600,015.36 |
DisclosureSEC source: 0001127602-18-001566 · form4.xml · nonDerivative · entry 2 Kuntz Richard · CIK 0001341125 · SrVP & Chief Scien, Clin, Reg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2018 Filed Jan 10, 2018 22:40 UTC |
Kuntz RichardSrVP & Chief Scien, Clin, Reg
|
Exercise / conversionOrdinary Shares | 35,492 | $37.53 | $1,332,014.76 |
DisclosureSEC source: 0001127602-18-001566 · form4.xml · nonDerivative · entry 1 Kuntz Richard · CIK 0001341125 · SrVP & Chief Scien, Clin, Reg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2018 Filed Jan 8, 2018 17:07 UTC |
HAKAMI HOOMANEVP & Group President Diabetes
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 26,158 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001127602-18-001398 · form4.xml · derivative · entry 3 HAKAMI HOOMAN · CIK 0001610035 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,159 Underlying: Ordinary Shares · 26,158 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 1,594 ordinary shares of New Medtronic for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. F4 · derivative.exercise_date: This option to purchase 29,743 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 29,743 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. F5 · derivative.exercise_date: This option to purchase 73,296 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 73,296 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| January 05, 2018 Filed Jan 8, 2018 17:07 UTC |
HAKAMI HOOMANEVP & Group President Diabetes
|
SaleOrdinary Shares | 26,158 | $85.00 | $2,223,430.00 |
DisclosureSEC source: 0001127602-18-001398 · form4.xml · nonDerivative · entry 2 HAKAMI HOOMAN · CIK 0001610035 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,828 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 05, 2018 Filed Jan 8, 2018 17:07 UTC |
HAKAMI HOOMANEVP & Group President Diabetes
|
Exercise / conversionOrdinary Shares | 26,158 | $62.76 | $1,641,676.08 |
DisclosureSEC source: 0001127602-18-001398 · form4.xml · nonDerivative · entry 1 HAKAMI HOOMAN · CIK 0001610035 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This balance increased by 356 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:40 UTC |
Hanson Bryan CEVP, President, MITG
|
SaleOrdinary Shares | 16,000 | $82.82 | $1,325,120.00 |
DisclosureSEC source: 0001127602-17-034959 · form4.xml · nonDerivative · entry 1 Hanson Bryan C · CIK 0001524349 · EVP, President, MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,818 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 01, 2017 Filed Dec 4, 2017 21:44 UTC |
Hanson Bryan CEVP, President, MITG
|
Tax withholdingOrdinary Shares | 4,249 | $81.27 | $345,316.23 |
DisclosureSEC source: 0001127602-17-033818 · form4.xml · nonDerivative · entry 1 Hanson Bryan C · CIK 0001524349 · EVP, President, MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,818 Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 22:25 UTC |
Hanson Bryan CEVP, President, MITG
|
SaleOrdinary Shares | 16,000 | $79.02 | $1,264,320.00 |
DisclosureSEC source: 0001127602-17-032709 · form4.xml · nonDerivative · entry 1 Hanson Bryan C · CIK 0001524349 · EVP, President, MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,067 F1 · kind: This sale was made pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: This balance increased by 511 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| October 28, 2017 Filed Oct 31, 2017 15:41 UTC |
Surface Carol ASVP, Chief HR Officer
|
Tax withholdingOrdinary Shares | 8,602 | $81.30 | $699,342.60 |
DisclosureSEC source: 0001127602-17-030603 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,871 F1 · balance_after: This balance increased by 258 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| October 16, 2017 Filed Oct 16, 2017 21:21 UTC |
Hanson Bryan CEVP, President, MITG
|
SaleOrdinary Shares | 16,000 | $78.03 | $1,248,480.00 |
DisclosureSEC source: 0001127602-17-029887 · form4.xml · nonDerivative · entry 1 Hanson Bryan C · CIK 0001524349 · EVP, President, MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,555 F1 · kind: This sale was made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 23:11 UTC |
ISHRAK OMARDirector · Chairman & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $38.81 | $0.00 |
DisclosureSEC source: 0001127602-17-027649 · form4.xml · derivative · entry 4 ISHRAK OMAR · CIK 0001523102 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,338 Underlying: Ordinary Shares · 100,000 shares Expires 2022-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: This option to purchase 290,338 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 290,338 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 23:11 UTC |
ISHRAK OMARDirector · Chairman & CEO
|
SaleOrdinary Shares | 140,407 | $81.63 | $11,461,423.41 |
DisclosureSEC source: 0001127602-17-027649 · form4.xml · nonDerivative · entry 2 ISHRAK OMAR · CIK 0001523102 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,096 F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.464 to $81.941, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 23:11 UTC |
ISHRAK OMARDirector · Chairman & CEO
|
Exercise / conversionOrdinary Shares | 100,000 | $38.81 | $3,881,000.00 |
DisclosureSEC source: 0001127602-17-027649 · form4.xml · nonDerivative · entry 1 ISHRAK OMAR · CIK 0001523102 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 668,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.